NASDAQ
Kaleido Biosciences, Inc. (KLDO) has a free cash flow growth of -7.90% as of Friday, May 29, 2026. This represents a 2.24% increase compared to its 12-month average of -8.08%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.